Ident. | Authors (with country if any) | Title |
---|
000132 (2020) |
Jrhau Lung [Taïwan] ; Yu-Shih Lin [Taïwan] ; Yao-Hsu Yang [Taïwan] ; Yu-Lun Chou ; Li-Hsin Shu [Taïwan] ; Yu-Ching Cheng [Taïwan] ; Hung Te Liu [Taïwan] ; Ching-Yuan Wu [Taïwan] | The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase. |
000213 (2020) |
Anh-Tien Ton [Canada] ; Francesco Gentile [Canada] ; Michael Hsing [Canada] ; Fuqiang Ban [Canada] ; Artem Cherkasov [Canada] | Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds. |
000243 (2020) |
Francesco Di Pierro [Oman] ; Alexander Bertuccioli [Italie] ; Ilaria Cavecchia [Italie] | Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus. |
000290 (2020) |
S K Kritas [Grèce] ; G. Ronconi [Italie] ; Al Caraffa [Italie] ; C E Gallenga [Italie] ; R. Ross [États-Unis] ; P. Conti [Italie] | Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy. |
000470 (2020) |
Miguel Angel Martinez [Espagne] | Compounds with therapeutic potential against novel respiratory 2019 coronavirus. |
000632 (2019) |
Mohammed Albratty [Arabie saoudite] ; Karam Ahmed El-Sharkawy [Arabie saoudite] ; Hassan Ahmed Alhazmi [Arabie saoudite] | Synthesis and evaluation of some new 1,3,4-oxadiazoles bearing thiophene, thiazole, coumarin, pyridine and pyridazine derivatives as antiviral agents. |
000645 (2019) |
Belén Martínez-Gualda [Espagne] ; Liang Sun [Belgique] ; Olaia Martí-Marí [Espagne] ; Carmen Mirabelli [Belgique] ; Leen Delang [Belgique] ; Johan Neyts [Belgique] ; Dominique Schols [Belgique] ; María-José Camarasa [Espagne] ; Ana San-Félix [Espagne] | Modifications in the branched arms of a class of dual inhibitors of HIV and EV71 replication expand their antiviral spectrum. |
000758 (2017) |
Karima Ighilahriz-Boubchir [Algérie] ; Baya Boutemeur-Kheddis ; Cherifa Rabia ; Malika Makhloufi-Chebli [Algérie] ; Maamar Hamdi ; Artur M. S. Silva | Recyclable Keggin Heteropolyacids as an Environmentally Benign Catalyst for the Synthesis of New 2-Benzoylamino-N-phenyl-benzamide Derivatives under Microwave Irradiations at Solvent-Free Conditions and the Evaluation of Biological Activity |
000818 (2017) |
Ujjini H. Manjunatha ; Sumiti Vinayak [États-Unis] ; Jennifer A. Zambriski [États-Unis] ; Alexander T. Chao ; Tracy Sy [États-Unis] ; Christian G. Noble ; Ghislain M. C. Bonamy ; Ravinder R. Kondreddi ; Bin Zou ; Peter Gedeck ; Carrie F. Brooks [États-Unis] ; Gillian T. Herbert [États-Unis] ; Adam Sateriale [États-Unis] ; Jayesh Tandel [États-Unis] ; Susan Noh [États-Unis] ; Suresh B. Lakshminarayana ; Siau H. Lim ; Laura B. Goodman [États-Unis] ; Christophe Bodenreider ; Gu Feng ; Lijun Zhang [République populaire de Chine] ; Francesca Blasco ; Juergen Wagner ; F. Joel Leong ; Boris Striepen [États-Unis] ; Thierry T. Diagana | A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis |
000824 (2016) |
Iwona E. Głowacka ; Rafał Gulej ; Piotr Grzonkowski ; Graciela Andrei ; Dominique Schols ; Robert Snoeck ; Dorota G. Piotrowska | Synthesis and the Biological Activity of Phosphonylated 1,2,3-Triazolenaphthalimide Conjugates |
000841 (2016) |
Dorota G. Piotrowska ; Graciela Andrei ; Dominique Schols ; Robert Snoeck ; Magdalena Grabkowska-Dru Yc | New Isoxazolidine-Conjugates of Quinazolinones—Synthesis, Antiviral and Cytostatic Activity |
000865 (2016) |
Sushanto Gouda [Inde] ; Gitishree Das [Corée du Sud] ; Sandeep K. Sen [Inde] ; Han-Seung Shin [Corée du Sud] ; Jayanta Kumar Patra [Corée du Sud] | Endophytes: A Treasure House of Bioactive Compounds of Medicinal Importance |
000895 (2016) |
Abdo A. Elfiky [Égypte, Italie] | Zika viral polymerase inhibition using anti‐HCV drugs both in market and under clinical trials |
000896 (2016) |
Eyüp Ba Aran [Turquie] ; Ay Egül Karaküçük-Iyido An [Turquie] ; Dominique Schols [Belgique] ; Emine Elçin Oruç-Emre [Turquie] | Synthesis of Novel Chiral Sulfonamide‐Bearing 1,2,4‐Triazole‐3‐thione Analogs Derived from D‐ and L‐Phenylalanine Esters as Potential Anti‐Influenza Agents |
000897 (2016) |
Tarek S. Ibrahim [Égypte] ; Amany M. M. Al-Mahmoudy [Égypte] ; Mohamed Elagawany [Égypte] ; Mohamed A. Ibrahim [Arabie saoudite, Égypte] ; Siva S. Panda [États-Unis] | Synthesis and Antiviral Bioassay of New Diphenyl Ether‐based Compounds |
000904 (2016) |
Abdelaaziz Ouahrouch [Maroc, Allemagne] ; Moha Taourirte [Maroc] ; Dominique Schols [Belgique] ; Robert Snoeck [Belgique] ; Graciela Andrei [Belgique] ; Joachim W. Engels [Allemagne] ; Hassan B. Lazrek [Maroc] | Design, Synthesis, and Antiviral Activity of Novel Ribonucleosides of 1,2,3‐Triazolylbenzyl‐aminophosphonates |
000930 (2015) |
Iwona E. Głowacka ; Graciela Andrei ; Dominique Schols ; Robert Snoeck ; Dorota G. Piotrowska | Phosphonylated Acyclic Guanosine Analogues with the 1,2,3-Triazole Linker |
000952 (2015) |
Caiao Guo ; Liang Ma ; Yudan Zhao ; Anlin Peng ; Biao Cheng ; Qiaoqiao Zhou ; Ling Zheng ; Kun Huang | Inhibitory effects of magnolol and honokiol on human calcitonin aggregation |
000966 (2015) |
John Gnabre [États-Unis] ; Robert Bates [États-Unis] ; Ru Chih Huang [États-Unis] | Creosote bush lignans for human disease treatment and prevention: Perspectives on combination therapy |
000A38 (2014) |
Emilia Bankowska [Pologne] ; Jan Balzarini [Belgique] ; Iwona E. Głowacka [Pologne] ; Andrzej E. Wr Blewski [Pologne] | Design, synthesis, antiviral and cytotoxic evaluation of novel acyclic phosphonate nucleotide analogues with a 5,6-dihydro-1H-[1,2,3]triazolo[4,5-d]pyridazine-4,7-dione system |
000A47 (2014) |
Adeyemi O. Adedeji [États-Unis] ; Stefan G. Sarafianos [États-Unis] | Antiviral Drugs Specific for Coronaviruses in Preclinical Development |